Perspectives with targets for the treatment of rheumatoid arthritis
Keywords:
rheumatoid arthritis, perspectives with targets, new drugs, epigeneticsAbstract
Rheumatoid arthritis is classified as a systemic polyarticular chronic autoimmune joint disease that mainly affects the hands and feet. The objective of this work is to show published information that contributes to directing the management of RA with new drugs. Epigenetic modifications can regulate gene expression without altering the DNA sequence. Regulation of non-coding RNAs (ncRNAs), DNA methylation, RNA methylation, and histone modifications are considered the main mechanisms of epigenetic regulations. Numerous investigations have established that various abnormalities in these mechanisms lead to the development of RA. This work summarizes new targets, including proteins, small molecular metabolites and regulators of epigenetics. They are promising molecular targets for drug discovery to alleviate disease onset and resolve non-response and partial responses, as well as adverse effects of current DMARDs. It is undeniable that further efforts are still needed to further define the underlying signaling pathways affected by these newly discovered molecules and to develop appropriate therapy methods.
Downloads
References
Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet Lond. Engl. 2016;388:2023-38.
Littlejohn EA, Monrad S. Early Diagnosis and Treatment of Rheumatoid Arthritis. Prim. Care: Clin. O. Pr. 2018;45:237-55.
Wegner N, Wait R, Sroka A, Eick S, Nguyen K, Lundberg K, Kinloch AJ, Culshaw S, Potempa J, Venables PJ. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and - enolase: Implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010;62:2662-72.
Aletaha D, Ramiro S. Diagnosis and Management of Rheumatoid Arthritis. JAMA. 2018;320:1360-72.
Lenz TL, Deutsch A, Han B, Hu X, Okada Y, Eyre S, Knapp M, Zhernakova A, Huizinga TW, Abecasis G, et al. Widespread non - additive and interaction e
ects within HLA loci modulate the risk of autoimmune diseases. Nat. Genet. 2015:47:1085-90.
Yap HY, Tee SZY, Wong MMT, Chow SK, Peh S, Teow Y. Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development. Cells. 2018;7:161-5.
Majorczyk E, Jasek M, Ploski R, Wagner M, Kosior A, Pawlik A, et al. Association of PTPN22 single nucleotide polymorphism with rheumatoid arthritis but not with allergic asthma. Eur. J. Hum. Genet. 2007;15:1043-8.
Firestein GS. Evolving Concepts of Rheumatoid Arthritis. Nature. 2003;423(6937):356-61. doi: 10.1038/nature01661
Turesson C, O’Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-Articular Disease Manifestations in Rheumatoid Arthritis: Incidence Trends and Risk Factors Over 46 Years. Ann Rheum Dis. 2003;62(8):722-7. doi: 10.1136/ard.62.8.722
Rice C, Ghandi-Das D, Negi A. Monitoring of Immunoglobulin Levels in RA Patients on Anti CD20, Rituximab. Rheumatology. 2020;59(Suppl 2):94. doi: 10.1093/rheumatology /keaa111.197
Ho CTK, Mok CC, Cheung TT, Kwok KY, Yip RML. Management of Rheumatoid Arthritis: 2019 Updated Consensus Recommendations From the Hong Kong Society of Rheumatology. Clin Rheumatol. 2019;38(12):3331-50. doi: 10.1007/s10067-019-04761-5
Gautam R, Singh M, Gautam S, Rawat JK, Saraf SA, Kaithwas G. Rutin Attenuates Intestinal Toxicity Induced by Methotrexate Linked With Anti-Oxidative and Anti-Inflammatory Effects. BMC Complement Altern Med. 2016;16(1):99. doi: 10.1186/s12906-016-1069-1
Choy E. Understanding the Dynamics: Pathways Involved in the Pathogenesis of Rheumatoid Arthritis. Rheumatololy (Oxford). 2012;51(Suppl 5):3-11. doi: 10.1093/rheumatology /kes113
Cheng Q, Wu H, Du Y. The Roles of Small-Molecule Inflammatory Mediators in Rheumatoid Arthritis. Scand J Immunol. 2021, 93(3):e12982. doi: 10.1111/sji.12982
Klein K, Gay S. Epigenetics in Rheumatoid Arthritis. Curr Opin Rheumatol. 2015;27(1):76-82. doi: 10.1097/BOR.0000000000000128
Reyes IV, Sánchez PE, Muñoz JF, Martı́nez GE, Garcı́a T, González V, et al. Citocinas (IL-15, IL-21 e IFN-g) en la artritis reumatoide: asociación con la positividad a los autoanticuerpos (RF, anti-CCP, anti-MCV y anti-PADI4) y actividad clínica. Clin Reumatol. 2019;38(11):3061-71. doi: 10.1007/s10067-019-04681-4
Cook AD, Louis C, Robinson MJ, Saleh R, Sleeman MA, Hamilton JA. Granulocyte Macrophage Colony-Stimulating Factor Receptor a Expression and its Targeting in Antigen-Induced Arthritis and Inflammation. Arthritis Res Ther. 2016;18(1):287. doi: 10.1186/s13075-016-1185-9
Goëb V, Aegerter P, Parmar R, Fardellone P, Vittecoq O, Conaghan PG, et al. Progression to Rheumatoid Arthritis in Early Inflammatory Arthritis Is Associated With Low IL-7 Serum Levels. Ann Rheumatic Dis. 2013;72(6):1032. doi: 10.1136/annrheumdis-2012-202377
Lee A, Qiao Y, Grigoriev G, Chen J, Park-Min KH, Park SH, et al. Tumor Necrosis Factor Alpha Induces Sustained Signaling and a Prolonged and Unremitting Inflammatory Response in Rheumatoid Arthritis Synovial Fibroblasts. Arthritis Rheum. 2013;65(4):928-38. doi: 10.1002/art.37853
Mease PJ. Adalimumab in the Treatment of Arthritis. Ther Clin Risk Manag. 2007;3(1):133-48. doi: 10.2147/tcrm.2007.3.1.133
Huang J, Fu X, Chen X, Li Z, Huang Y, Liang Ch. Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis. JOURNAL Frontiers in Immunology. 2021;12:2716. DOI=10.3389/fimmu.2021.686155
Bouchareychas L, Grössinger EM, Kang M, Qiu H, Adamopoulos IE. Critica Role of LTB4/BLT1 in IL-23-Induced Synovial Inflammation and Osteoclastogenesis via NF-kb. J Immunol (Baltimore Md: 1950). 2017;198(1):452-60. doi: 10.4049/jimmunol.1601346
Qu CH, Hou Y, Bi YF, Han QR, Jiao CH, Zou QF. Diagnostic Values of Serum IL-10 and IL-17 in Rheumatoid Arthritis and Their Correlation With Serum 14-3-3h Protein. Eur Rev Med Pharmacol Sci. 2019;23(5):1899-906. doi: 10.26355/eurrev_201903_17227
Brzustewicz E, Bryl E. The Role of Cytokines in the Pathogenesis of Rheumatoid Arthritis–Practical and Potential Application of Cytokines as Biomarkers and Targets of Personalized Therapy. Cytokine. 2015;76(2):527-36. doi: 10.1016/j.cyto.2015.08.260
Tanaka Y, Takeuchi T, Yamanaka H, Nanki T, Umehara H, Yasuda N, et al. A Phase 2 Study of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients With Rheumatoid Arthritis Inadequately Responding to Biological Disease-Modifying Antirheumatic Drugs. Modern Rheumatol. 2021;31(4):783-9. doi: 10.1080/14397595.2020.1868675
Yokomizo T, Nakamura M, Shimizu T. Leukotriene Receptors as Potential Therapeutic Targets. J Clin Invest. 2018;128(7):2691-701. doi: 10.1172/jci97946
Ramon S, Bancos S, Serhan CN, Phipps RP. Lipoxin A₄ Modulates Adaptive Immunity by Decreasing Memory B-Cell Responses via an ALX/FPR2- Dependent Mechanism. Eur J Immunol. 2014;44(2):357-69. doi: 10.1002/eji.201343316
Manfredi AA, Baldini M, Camera M, Baldissera E, Brambilla M, Peretti G, et al. Anti-Tnfa Agents Curb Platelet Activation in Patients With Rheumatoid Arthritis. Ann Rheum Dis. 2016;75(8):1511-20. doi: 10.1136/annrheumdis-2015-208442
Mateen S, Moin S, Shahzad S, Khan AQ. Level of Inflammatory Cytokines in Rheumatoid Arthritis Patients: Correlation With 25-Hydroxy Vitamin D and Reactive Oxygen Species. PloS One. 2017;12(6):e0178879. doi: 10.1371/journal.pone.0178879
Wang KC, Liu YC, El-Shazly M, Shih SP, Du YC, Hsu YM, et al. The Antioxidant From Ethanolic Extract of Rosa Cymosa Fruits Activates Phosphatase and Tensin Homolog In Vitro and In Vivo: A New Insight on Its Antileukemic Effect. Int J Mol Sci. 2019;20(8):1935-58. doi: 10.3390/ijms20081935
Liu Y, Wei W, Hong C, Wang Y, Sun X, Ma J, et al. Calreticulin Induced Endothelial ICAM-1 Up-Regulation Associated With Tristetraprolin Expression Alteration Through PI3K/Akt/eNOS/p38 MAPK Signaling Pathway in Rheumatoid Arthritis. Mol Immunol. 2019;107:10-20. doi: 10.1016/j.molimm.2019.01.005
Takatani Y, Ono K, Suzuki H, Inaba M, Sawada M, Matsuda N. Inducible Nitric Oxide Synthase During the Late Phase of Sepsis Is Associated With Hypothermia and Immune Cell Migration. Lab Invest. 2018;98(5):629-39. doi: 10.1038/s41374-018-0021-z
Di Marzo V, Bifulco M, De Petrocellis L. The Endocannabinoid System and its Therapeutic Exploitation. Nat Rev Drug Discovery. 2004;3(9):771-84. doi: 10.1038/nrd1495
Kinsey SG, Naidu PS, Cravatt BF, Dudley DT, Lichtman AH. Fatty Acid Amide Hydrolase Blockade Attenuates the Development of Collagen-Induced Arthritis and Related Thermal Hyperalgesia in Mice. Pharmacol Biochem Behav. 2011;99(4):718-25. doi: 10.1016/j.pbb.2011.06.022
Nakano K, Whitaker JW, Boyle DL, Wang W, Firestein GS. DNA Methylome Signature in Rheumatoid Arthritis. Ann Rheum Dis. 2013;72(1):110-7. doi: 10.1136/annrheumdis-2012-201526
Gilbert WV, Bell TA, Schaening C. Messenger RNA Modifications: Form, Distribution, and Function. Sci (New York NY). 2016;352(6292):1408-12. doi: 10.1126/science.aad8711
Jiang H, Cao K, Fan C, Cui X, Ma Y, Liu J. Transcriptome-Wide High-Throughput M6a Sequencing of Differential M6a Methylation Patterns in the Human Rheumatoid Arthritis Fibroblast-Like Synoviocytes Cell Line MH7A. J Inflammation Res. 2021;14:575-86. doi: 10.2147/jir.S296006
Wang J, Yan S, Lu H, Wang S, Xu D. METTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-kb Signaling Pathway. Mediators Inflammation. [Internet]. 2019 [Acceso: 16/01/2022] :3120391. doi: 10.1155/2019/3120391. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854952/
Downloads
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
